Although cervical carcinoma cells may express the human papillomavirus protein E6 and E7, they fail to induce an effective specific cytotoxic T lymphocyte response. Recent studies suggest that expression of CD-80(B7-1) on tumor cells is effective to induce anfitumor immune responses.1,2 In our study, CD-80 gene was transfected into human Hela cell line with a CD-80expression plasmid (B7-1+pcDNA3) by electroporation,then the immunogenecity of the modified Hela cell was tested in TLMC (tumor lymphocyte mixed culture)system. [3H]thymidine lymphocyte proliferation assays showed that the response of human peripheral blood lymphocytes (PBLS) to CD-80 positive Hela cells demonstrated a substantial increase in cell proliferation compared to the response to control cells. Cocultivation of allogeneic PBLs with CD-80 positive tumor cells for three days can induce an increased secretion of IL-2. Our results demonstrate an immunostimulatory effect of CD-80 expression on cervical cancer cells, which provides a basis for the development of a therapeutic tumor vaccine.